Oxytocin treatment in children with Prader–Willi syndrome: A double‐blind, placebo‐controlled, crossover study
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Prader–Willi syndrome (PWS) is a rare, complex multisystem genetic disorder which includes hypothalamic dysfunction, hyperphagia, cognitive and behavioral problems, increased anxiety, and compulsive behaviors. Individuals with PWS have a deficit of oxytocin producing neurons in the paraventricular nucleus of the hypothalamus. Oxytocin plays a role in regulation of feeding behaviors, social interactions, and emotional reactivity, which are all issues that significantly affect the quality of life for individuals with this syndrome. We performed a double‐blind, placebo‐controlled, crossover study in 24 children with PWS at three academic institutions using 5 days of intranasal oxytocin (IN‐OT) or 5 days of intranasal placebo spray, followed by a 4 week washout period, and then patients returned for 5 days of treatment with the alternate source. Questionnaires, including the Aberrant Behavior Checklist, Social Responsiveness Scale, Repetitive Behavior Scale − Revised, and the Hyperphagia Questionnaire, as well as Clinical Global Impression scales were administered. Blood testing for sodium, potassium, and glucose levels on days 2, 4, and 6, and a 24 hr diet recall. All scales factor improvement from Day 3 to Day 6 favored oxytocin over placebo. No single factor showed a statistically significant difference (P < 0.05) between groups at Day 6. The drug effect appeared to be diminished at Day 14. There was no evidence of a difference between oxytocin and placebo in safety lab parameters, 60 min post dose vital signs, weight, or diet parameters. The results from this study suggest that low dose intranasal oxytocin is safe for individuals with PWS and may result in reduction in appetite drive, and improvements in socialization, anxiety, and repetitive behaviors. Further, long‐term studies with a larger population of participants are necessary to confirm these findings. The results of this study are encouraging that oxytocin may be a safe and effective treatment for many of the issues that negatively impact individuals with PWS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and analysis of pilot studies: recommendations for good practice
Lancaster, G. A., Dodd, S., & Williamson, P. R. (2004) · Journal of Evaluation in Clinical Practice · doi:10.1111/j..2002.384.doc.x · Cited by 2,572
Constantino, J. N., Davis, S. A., Todd, R. D., Schindler, M. K., Gross, M. M., Brophy, S. L., Metzger, L. M., Shoushtari, C. S., Splinter, R., & Reich, W. (2003) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1025014929212 · Cited by 1,611 · cited 1×
“Validated questionnaires were used in the study to evaluate the effects of IN-OT on behavior, socialization, and anxiety, including: Aberrant Behavior Checklist (ABC); Repetitive Behavior Scale-Revised (RBS-R) (Lam and Aman, 2007); and Social Responsiveness Scale (SRS) (Constantino et al., 2003).”
MethodInsel, T. R. (2010) · Neuron · doi:10.1016/j.neuron.2010.03.005 · Cited by 1,044
Lam, K. S. L., & Aman, M. G. (2007) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-006-0213-z · Cited by 793
Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics
Manning, M., Misicka, A., Olma, A., Bankowski, K., Stoev, S., Chini, B., Durroux, T., Mouillac, B., Corbani, M., & Guillon, G. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2012.02303.x · Cited by 423 · cited 1×
“While OT exposure is associated with positive sociality and reduced anxiety, AVP is anxiogenic (Francis et al., 2014; Insel, 2010; Manning et al., 2012).”
BackgroundSala, M., Braida, D., Lentini, D., Busnelli, M., Bulgheroni, E., Capurro, V., Finardi, A., Donzelli, A., Pattini, L., Rubino, T., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.12.022 · Cited by 375 · cited 1×
“OT knockout mice have been shown tomaintain olfaction and cognitive performance, but suffer deficits in social recognition that were recovered by intraventricular OT but not by AVP administration (Sala et al., 2011).”
BackgroundPilot and feasibility studies come of age!
Lancaster, G. A. (2015) · Pilot and Feasibility Studies · doi:10.1186/2055-5784-1-1 · Cited by 260
Schaller, F., Watrin, F., Sturny, R., Massacrier, A., Szepetowski, P., & Muscatelli, F. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq424 · Cited by 234
Chronic and acute intranasal oxytocin produce divergent social effects in mice
Huang, H., Michetti, C., Busnelli, M., Managò, F., Sannino, S., Scheggia, D., Giancardo, L., Sona, D., Murino, V., Chini, B., et al. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.310 · Cited by 199 · cited 1×
“In mice, long term administration of oxytocin results in reduced oxytocin receptors throughout the brain (Huang et al., 2014).”
BackgroundA double-blind randomized controlled trial of oxytocin nasal spray in Prader Willi syndrome
Einfeld, S. L., Smith, E., McGregor, I. S., Steinbeck, K., Taffe, J., Rice, L. J., Horstead, S. K., Rogers, N., Hodge, M. A., & Guastella, A. J. (2014) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36653 · Cited by 131 · cited 3×
“However, another study of 30 adolescents and adults with PWS with twice daily dosing of IN-OT found no improvements in behaviour, hyperphagia, or compulsivity, but an increase in temper outbursts with higher doses of oxytocin (Einfeld et al., 2014).”
BackgroundResultInfluential
Cited by
Prader-Willi Syndrome - Clinical Genetics, Diagnosis and Treatment Approaches: An Update
Butler, M. G., Miller, J. L., & Forster, J. L. (2019) · Current Pediatric Reviews · doi:10.2174/1573396315666190716120925 · Cited by 355
Self-citationvan Iersel, L., Brokke, K. E., Adan, R. A. H., Bulthuis, L. C. M., van den Akker, E. L. T., & van Santen, H. M. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00017 · Cited by 146
Müller, H. L., Tauber, M., Lawson, E. A., Özyurt, J., Bison, B., Martinez-Barbera, J.-P., Puget, S., Merchant, T. E., & van Santen, H. M. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00351-z · Cited by 144
The sociability spectrum: evidence from reciprocal genetic copy number variations
López-Tobón, A., Trattaro, S., & Testa, G. (2020) · Molecular Autism · doi:10.1186/s13229-020-00347-0 · Cited by 20
Metadata
- Authors
- Miller, J. L., Tamura, R., Butler, M. G., Kimonis, V., Sulsona, C., Gold, J., & Driscoll, D. J.
- Venue
- American Journal of Medical Genetics Part A
- Publisher
- Wiley
- Published
- 2017-03-30
- Volume
- 173
- Issue
- 5
- Pages
- 1243-1250
- ISSN
- 1552-4825 (ISSN-L)
- 1552-4833
- OpenAlex
- W2598809163
- Cited by
- 145
- References
- 15
- FWCI
- 27.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Oxytocin treatment in children with Prader–Willi syndrome: A double‐blind, placebo‐controlled, crossover study. https://app.cochat.ai/papers/10.1002/ajmg.a.38160
- The paper
- Miller, J. L., Tamura, R., Butler, M. G., Kimonis, V., Sulsona, C., Gold, J., & Driscoll, D. J. (2017). Oxytocin treatment in children with Prader–Willi syndrome: A double‐blind, placebo‐controlled, crossover study. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.38160
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.